Cargando…
Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study
BACKGROUND: Colonoscopy is widely regarded to be the gold standard for colorectal cancer (CRC) detection. Recent studies, however, suggest that the effectiveness of colonoscopy is mostly confined to tumors on the left side of the colon (descending, sigmoid, rectum), and that the technology has poor...
Autores principales: | Chao, Samuel, Ying, Jay, Liew, Gailina, Marshall, Wayne, Liew, Choong-Chin, Burakoff, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734158/ https://www.ncbi.nlm.nih.gov/pubmed/23876008 http://dx.doi.org/10.1186/1756-9966-32-44 |
Ejemplares similares
-
A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia
por: Yip, Kok-Thye, et al.
Publicado: (2010) -
Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers
por: Su, Ming-Wei, et al.
Publicado: (2022) -
Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma
por: Guo, Dongming, et al.
Publicado: (2019) -
Microvolt T-wave alternans testing is abnormal both in left- and right-sided pathology
por: Mizia-Stec, Katarzyna
Publicado: (2016) -
Right- and left-sided colorectal cancers respond differently to cetuximab
por: Wang, Feng, et al.
Publicado: (2015)